Retrospective multicenter study finds fluconazole resistance increases recurrence but not mortality in Candida parapsilosis candidemia, indicating persistent management challenges.
Our results suggest that fluconazole resistance is not associated with a higher mortality risk in patients with C. parapsilosis BSI, though 1-year recurrence rates were higher in the FLZR-CP group.
No takes yet. Share an insight, caveat, or question.
Vena et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: